Literature DB >> 7869426

Regional CNS uptake of blood-borne nerve growth factor.

R Loy1, G Taglialatela, L Angelucci, D Heyer, R Perez-Polo.   

Abstract

Nerve growth factor (NGF), in addition to being a neurotrophic substance, has effects on the endocrine and immune systems. For example, intravenous injection of NGF results in a cascade of events leading to an increase in glucocorticoid secretion. While this response appears to be mediated centrally, there has been no evidence that circulating NGF has access to the CNS. Using intravenous injections of 125I-NGF, we find specific uptake at 1 hr but none at 6 hr, into homogenates of the basal forebrain, cerebellum, frontal cortex, hippocampus, and olfactory bulb. By autoradiography, uptake is localized to circumventricular organs, deep layers of the cerebellum, and all layers of the hippocampal region CA1, but not the dentate gyrus. Thus, uptake of blood-borne NGF could affect the hypothalamic-pituitary-adrenal axis via binding to NGF receptors present in the hippocampus. However, the sources of endogenous NGF, the mechanism of access through the blood-brain barrier, the eventual fate of NGF entering from the blood, and the physiological significance of this uptake remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7869426     DOI: 10.1002/jnr.490390311

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

Review 1.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.

Authors:  W M Saltzman; M W Mak; M J Mahoney; E T Duenas; J L Cleland
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy.

Authors:  C Bäckman; G M Rose; B J Hoffer; M A Henry; R T Bartus; P Friden; A C Granholm
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

4.  The nerve of ovulation-inducing factor in semen.

Authors:  Marcelo H Ratto; Yvonne A Leduc; Ximena P Valderrama; Karin E van Straaten; Louis T J Delbaere; Roger A Pierson; Gregg P Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

5.  Classification of HIV-1-mediated neuronal dendritic and synaptic damage using multiple criteria linear programming.

Authors:  Jialin Zheng; Wei Zhuang; Nian Yan; Gang Kou; Hui Peng; Clancy McNally; David Erichsen; Abby Cheloha; Shelley Herek; Chris Shi
Journal:  Neuroinformatics       Date:  2004

6.  Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study.

Authors:  Song Tan; Rui-Hao Wang; Hui-Xia Niu; Chang-He Shi; Cheng-Yuan Mao; Rui Zhang; Bo Song; Shi-Lei Sun; Xin-Jing Liu; Hai-Man Hou; Yu-Tao Liu; Yuan Gao; Hui Fang; Xiang-Dong Kong; Yu-Ming Xu
Journal:  Chin Med J (Engl)       Date:  2015-02-05       Impact factor: 2.628

Review 7.  Effect of the Camelid's Seminal Plasma Ovulation-Inducing Factor/β-NGF: A Kisspeptin Target Hypothesis.

Authors:  Khalid El Allali; Najlae El Bousmaki; Hassan Ainani; Valérie Simonneaux
Journal:  Front Vet Sci       Date:  2017-06-30

8.  Intracerebroventricular administration of nerve growth factor induces gliogenesis in sensory ganglia, dorsal root, and within the dorsal root entry zone.

Authors:  Johannes C M Schlachetzki; Donald P Pizzo; Debbi A Morrissette; Jürgen Winkler
Journal:  Biomed Res Int       Date:  2014-03-16       Impact factor: 3.411

9.  The Evaluation of Nerve Growth Factor Over Expression on Neural Lineage Specific Genes in Human Mesenchymal Stem Cells.

Authors:  Yousef Mortazavi; Fatemeh Sheikhsaran; Gholamreza Khamisipour Khamisipour; Masoud Soleimani; Ali Teimuri; Somayeh Shokri
Journal:  Cell J       Date:  2016-05-30       Impact factor: 2.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.